Canada markets closed

Nexstim Plc (NXTMH.HE)

Helsinki - Helsinki Real Time Price. Currency in EUR
Add to watchlist
4.4900+0.1100 (+2.51%)
At close: 6:29PM EEST
Full screen
Previous Close4.3800
Open4.5000
Bid4.4200 x N/A
Ask4.4900 x N/A
Day's Range4.4300 - 4.6300
52 Week Range3.0378 - 9.6302
Volume25,726
Avg. Volume25,713
Market Cap30.023M
Beta (5Y Monthly)2.25
PE Ratio (TTM)N/A
EPS (TTM)-0.7910
Earnings DateAug. 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury

    Press release, Helsinki, 15 October 2021 at 9 AM (EEST) Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a research project utilizing the Company’s SmartFocus® TMS technology has been awarded the Human Brain Project (HBP) Innovation Award. Professor Marcello Massimini and his team from the Department of Clinical and Biomedical Sciences at Un

  • GlobeNewswire

    Nexstim Receives Two NBS System Orders from Hospitals in Europe

    Press release, Helsinki, 4 October 2021 at 10 AM (EEST) Nexstim Receives Two NBS System Orders from Hospitals in Europe Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System order and a NBS System upgrade order from European hospitals. The NBS system order is from a new customer and the upgrade order was made by an existing customer for Nexstim. These new NBS5 platform deliveries to the hospitals enable neurosurgical diagnostics as well as MD

  • GlobeNewswire

    NEXSTIM PLC PROVIDES AN UPDATE ON THE PILOT STUDY IN CHRONIC PAIN TREATMENT AT HELSINKI UNIVERSITY HOSPITAL

    NEXSTIM PLC PROVIDES AN UPDATE ON THE PILOT STUDY IN CHRONIC PAIN TREATMENT AT HELSINKI UNIVERSITY HOSPITAL Company announcement, Inside information, Helsinki, September 29, 2021 at 15.00 (EET) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") provides an update on the pilot study on the use of accelerated iTBS protocol in treatment of chronic neuropathic pain with Nexstim NBT® System at Helsinki University Hospital. The treatment of all except one patient has been completed in this to